(Q34366444)

1 August 2017

1 reference

title

The rise and fall of antimicrobial resistance (English)

1 reference

1 August 2017

antimicrobial resistance

1 reference

1

M Lipsitch

1 reference

1 August 2017

1 September 2001

1 reference

1 August 2017

Trends in Microbiology

1 reference

1 August 2017

9

1 reference

1 August 2017

438-444

1 reference

1 August 2017

9

1 reference

Update in infectious diseases

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Why have group A streptococci remained susceptible to penicillin? Report on a symposium.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Genetics and mechanisms of glycopeptide resistance in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

beta-Lactamases: protein evolution in real time

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Emerging mechanisms of fluoroquinolone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Intercontinental spread of a new antibiotic resistance gene on an epidemic plasmid.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Glycopeptide-resistant enterococci: a decade of experience

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Effects of antiviral usage on transmission dynamics of herpes simplex virus type 1 and on antiviral resistance: predictions of mathematical models

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

The biological cost of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Application of fluoroquinolone pharmacodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Nonadherence in tuberculosis treatment: predictors and consequences in New York City.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Dynamics and control of the transmission of gonorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Multidrug resistance in Yersinia pestis mediated by a transferable plasmid

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

The population genetics of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Evaluating treatment protocols to prevent antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Successful interventions for gram-negative resistance to extended-spectrum beta-lactam antiobiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Design and analysis issues in cluster-randomized trials of interventions against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Eradication of epidemic methicillin-gentamicin-resistant staphylococcus aureus in an intensive care nursery.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

Antibiotic selection of multiply resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902130-8

7 January 2021

10.1016/S0966-842X(01)02130-8

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11553456